Skip to main content
. 2021 Jan 29;11:631170. doi: 10.3389/fphar.2020.631170

FIGURE 6.

FIGURE 6

Plots of the cluster analyses for all types of outcomes. (A) Clinical effectiveness rate (x-axis) and leukopenia (y-axis); (B) Performance status (x-axis) and leukopenia (y-axis); (C) Clinical effectiveness rate (x-axis), performance status (y-axis), and leukopenia (z-axis); (D) Clinical effectiveness rate (x-axis), performance status (y-axis), and hemoglobin (z-axis); (E) Clinical effectiveness rate (x-axis), performance status (y-axis), and thrombocytopenia (z-axis); (F) Clinical effectiveness rate (x-axis), performance status (y-axis), and gastrointestinal reactions (z-axis). Note: Interventions with the same color belong to the same cluster, and interventions located in the upper-right corner indicate optimal therapy for two different outcomes. NP, vinorelbine and cisplatin; ADI, Aidi injection; AI, Astragalus injection; CSI, Chansu injection; CKSI, Compound kushen injection; DLSI, Delisheng injection; HCSI, Huachansu injection; JOEI, Javanica oil emulsion injection; KAI, Kangai injection; KLTI, Kanglaite injection; SFI, Shenfu injection; SMI, Shenmai injection; SQFZI, Shenqifuzheng injection; SGMI, Shengmai injection; XAPI, Xiaoaiping injection.